Honors & Awards

  • Short-term stay fellowship, University of Granada (2018)
  • Short-term stay fellowship, Ministry of Education of Spain (2017)
  • Predoctoral fellowship FPU, Ministry of Education of Spain (2015-2019)

Professional Education

  • Postdoctoral fellow, University of Granada (2019)
  • Doctor of Philosophy, Universidad De Granada (2019)
  • Master of Science, Universidad De Granada (2014)
  • Bachelor of Science, Universidad De Granada (2013)

Stanford Advisors

All Publications

  • High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment. Cell reports Gonzalez, V. D., Huang, Y., Delgado-Gonzalez, A., Chen, S., Donoso, K., Sachs, K., Gentles, A. J., Allard, G. M., Kolahi, K. S., Howitt, B. E., Porpiglia, E., Fantl, W. J. 2021; 36 (9): 109632


    Tubo-ovarian high-grade serous carcinoma (HGSC) is unresponsive to immune checkpoint blockade despite significant frequencies of exhausted Tcells. Here we apply mass cytometry and uncover decidual-like natural killer (dl-NK) cell subpopulations (CD56+CD9+CXCR3+KIR+CD3-CD16-) in newly diagnosed HGSC samples that correlate with both tumor and transitioning epithelial-mesenchymal cell abundance. We show different combinatorial expression patterns of ligands for activating and inhibitory NK receptors within three HGSC tumor compartments: epithelial (E), transitioning epithelial-mesenchymal (EV), and mesenchymal (vimentin expressing [V]), with a more inhibitory ligand phenotype in V cells. In cocultures, NK-92 natural killer cells acquire CD9 from HGSC tumor cells by trogocytosis, resulting in reduced anti-tumor cytokine production and cytotoxicity. Cytotoxicity in these cocultures is restored with a CD9-blocking antibody or CD9 CRISPR knockout, thereby identifying mechanisms of immune suppression in HGSC. CD9 is widely expressed in HGSC tumors and so represents an important new therapeutic target with immediate relevance for NK immunotherapy.

    View details for DOI 10.1016/j.celrep.2021.109632

    View details for PubMedID 34469729

  • Mass Cytometry Tags: Where Chemistry Meets Single-Cell Analysis. Analytical chemistry Delgado-Gonzalez, A. n., Sanchez-Martin, R. M. 2020


    Mass cytometry is a highly multiparametric proteomic technology that allows the measurement and quantification of nearly 50 markers with single-cell resolution. Mass cytometry reagents are probes tagged with metal isotopes of defined mass and act as reporters. Metals are detected using inductively coupled plasma time-of-flight mass spectrometry (ICP-TOF-MS). Many different types of mass-tag reagents have been developed to afford myriad applications. We have classified these compounds into polymer-based mass-tag reagents, nonpolymer-based mass-tag reagents, and inorganic nanoparticles. Metal-chelating polymers (MCPs) are widely used to profile and quantify cellular biomarkers; however, both the range of metals that can be detected and the metal signals have to be improved. Several strategies such as the inclusion of chelating agents or highly branched polymers may overcome these issues. Biocompatible materials such as polystyrene and inorganic nanoparticles are also of profound interest in mass cytometry. While polystyrene allows the inclusion of a wide variety of metals, the high metal content of inorganic nanoparticles offers an excellent opportunity to increase the signal from the metals to detect low-abundance biomarkers. Nonpolymer-based mass-tag reagents offer multiple applications: cell detection, cell cycle property determination, biomarker detection, and mass-tag cellular barcoding (MCB). Recent developments have been achieved in live cell barcoding by targeting proteins (CD45, b2m, and CD298), by using small and nonpolar probes or by ratiometric barcoding. From this perspective, the principal applications, strengths, and shortcomings of mass-tag reagents are highlighted, summarized, and discussed, with special emphasis on mass-tag reagents for MCB. Thereafter, the future perspectives of mass-tag reagents are discussed considering the current state-of-the-art technologies.

    View details for DOI 10.1021/acs.analchem.0c03560

    View details for PubMedID 33320535

  • PCR-free and chemistry-based technology for miR-21 rapid detection directly from tumour cells TALANTA Delgado-Gonzalez, A., Robles-Remacho, A., Marin-Romero, A., Detassis, S., Lopez-Longarela, B., Javier Lopez-Delgado, F., de Miguel-Perez, D., Guardia-Monteagudo, J. J., Antonio Fara, M., Tabraue-Chavez, M., Pernagallo, S., Sanchez-Martin, R. M., Diaz-Mochon, J. J. 2019; 200: 51–56


    miRNAs are well known for being implicated in a myriad of biological situations, including those related to serious diseases. Amongst miRNAs, miRNA-21 has the spotlight as it is reported to be up-regulated in multiple severe pathological conditions, being its quantification a key point in medicine. To date, most of the techniques for miRNA quantification have shown to be less effective than expected; thus, we herein present a novel, rapid, cost-effective, robust and PCR-free approach, based on dynamic chemistry, for the identification and quantification of miRNA directly from tumour cells using both FACS and a fluorescent microplate. This dynamic chemistry novel application involves bead based reagents and allows quantifying the number of miR-21 molecules presented in MDA-MB-468 and H1975 tumour cells.

    View details for DOI 10.1016/j.talanta.2019.03.039

    View details for Web of Science ID 000468715300007

    View details for PubMedID 31036216

  • Drug "Clicking" on Cell-Penetrating Fluorescent Nanoparticles for In Cellulo Chemical Proteomics BIOCONJUGATE CHEMISTRY Valero, T., Delgado-Gonzalez, A., Diego Unciti-Broceta, J., Cano-Cortes, V., Perez-Lopez, A. M., Unciti-Broceta, A., Sanchez Martin, R. M. 2018; 29 (9): 3154–60


    Chemical proteomics approaches are widely used to identify molecular targets of existing or novel drugs. This manuscript describes the development of a straightforward approach to conjugate azide-labeled drugs via click chemistry to alkyne-tagged cell-penetrating fluorescent nanoparticles as a novel tool to study target engagement and/or identification inside living cells. A modification of the Baeyer test for alkynes allows monitoring the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, guaranteeing the presence of the drug on the solid support. As a proof of concept, the conjugation of the promiscuous kinase inhibitor dasatinib to Cy5-labeled nanoparticles is presented. Dasatinib-decorated fluorescent nanoparticles efficiently inhibited its protein target SRC in vitro, entered cancer cells, and colocalized with SRC in cellulo.

    View details for DOI 10.1021/acs.bioconjchem.8b00481

    View details for Web of Science ID 000445439500029

    View details for PubMedID 30122043

  • Metallofluorescent Nanoparticles for Multimodal Applications ACS OMEGA Delgado-Gonzalez, A., Garcia-Fernandez, E., Valero, T., Cano-Cortes, M., Ruedas-Rama, M. J., Unciti-Broceta, A., Sanchez-Martin, R. M., Diaz-Mochon, J. J., Orte, A. 2018; 3 (1): 144–53


    Herein, we describe the synthesis and application of cross-linked polystyrene-based dual-function nano- and microparticles containing both fluorescent tags and metals. Despite containing a single dye, these particles exhibit a characteristic dual-band fluorescence emission. Moreover, these particles can be combined with different metal ions to obtain hybrid metallofluorescent particles. We demonstrate that these particles are easily nanofected into living cells, allowing them to be used for effective fingerprinting in multimodal fluorescence-based and mass spectrometry-based flow cytometry experiments. Likewise, the in situ reductions of the metal ions enable other potential uses of the particles as heterogeneous catalysts.

    View details for DOI 10.1021/acsomega.7b01984

    View details for Web of Science ID 000427933200016

    View details for PubMedID 30023770

    View details for PubMedCentralID PMC6044963